Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

TELA Bio, Inc. - Common stock (NQ:TELA)

0.9987 +0.0287 (+2.96%)
Streaming Delayed Price Updated: 2:50 PM EDT, Sep 14, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about TELA Bio, Inc. - Common stock

< Previous 1 2 3 4 5 6 7 Next >
News headline image
TELA Bio Announces COO / CFO Transition and Strategic Cost Reduction Initiative
Company to reduce annual operating expenses by $17.0 million or 18% as part of broader efficiency program 
From TELA Bio, Inc.
Via GlobeNewswire
News headline image
TELA Bio (TELA) Q2 2026 Earnings Call Transcript ↗
Revenue declined 4% as OviTex PRS unit volumes fell, but international sales surged 26%. 
Via The Motley Fool
Topics Earnings World Trade
News headline image
TELA Bio Reports Second Quarter 2026 Financial Results
From TELA Bio, Inc.
Via GlobeNewswire
News headline image
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From TELA Bio, Inc.
Via GlobeNewswire
TELA Bio (NASDAQ:TELA) Reports Mixed Q1 Results with Revenue Beat but Wider Loss and Cautious Q2 Guidance ↗
Via Chartmill
News headline image
TELA Bio Announces Appointment of Heather Getz as Chief Executive Officer and Director
From TELA Bio, Inc.
Via GlobeNewswire
News headline image
TELA Bio to Participate in the Canaccord Genuity 46th Annual Growth Conference
From TELA Bio, Inc.
Via GlobeNewswire
News headline image
TELA Bio to Announce Second Quarter 2026 Financial Results
From TELA Bio, Inc.
Via GlobeNewswire
News headline image
After Fifty Years of Implants, a Newly Public Biotech Is Trying to Rebuild the Breast Instead
Issued on behalf of Conexeu Sciences Inc. 
From Biotech Insider
Via GlobeNewswire
TELA Bio Inc (NASDAQ:TELA) Reports Record Q4 Revenue but Misses Sales Estimates ↗
Via Chartmill
News headline image
TELA Bio Reports First Quarter 2026 Financial Results
From TELA Bio, Inc.
Via GlobeNewswire
News headline image
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From TELA Bio, Inc.
Via GlobeNewswire
Which stocks are moving on Friday? ↗
Via Chartmill
News headline image
TELA Bio Announces Strategic Board Refreshment with Four Highly Experienced Commerical Leaders to Accelerate Growth and Drive Path to Profitability; The Company Also Reports Preliminary First Quarter 2026 Revenues
From TELA Bio, Inc.
Via GlobeNewswire
News headline image
TELA Bio to Announce First Quarter 2026 Financial Results
From TELA Bio, Inc.
Via GlobeNewswire
News headline image
TELA Bio Analysts Cut Their Forecasts After Q4 Results ↗
TELA Bio (NASDAQ:TELA) reported mixed Q4 results, with higher losses but lower sales than expected. Analysts lowered price targets for the stock. 
Via Benzinga
News headline image
TELA Bio (TELA) Q4 2025 Earnings Call Transcript ↗
TELA Bio (TELA) Q4 2025 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
News headline image
TELA Bio Reports Fourth Quarter and Full Year 2025 Financial Results
From TELA Bio, Inc.
Via GlobeNewswire
News headline image
TELA Bio to Announce Fourth Quarter and Full Year 2025 Financial Results
From TELA Bio, Inc.
Via GlobeNewswire
News headline image
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From TELA Bio, Inc.
Via GlobeNewswire
News headline image
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From TELA Bio, Inc.
Via GlobeNewswire
News headline image
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From TELA Bio, Inc.
Via GlobeNewswire
News headline image
TELA Bio to Participate in the Piper Sandler 37th Annual Healthcare Conference
From TELA Bio, Inc.
Via GlobeNewswire
News headline image
Alphabet To Rally More Than 12%? Here Are 10 Top Analyst Forecasts For Tuesday ↗
 
Via Benzinga
News headline image
What's going on in today's after hours session ↗
As the regular session of the US market on Monday comes to an end, let's delve into the after-hours session and discover the top gainers and losers shaping the post-market sentiment. 
Via Chartmill
News headline image
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From TELA Bio, Inc.
Via GlobeNewswire
News headline image
These Analysts Cut Their Forecasts On TELA Bio After Q3 Earnings ↗
 
Via Benzinga
News headline image
TELA Bio Inc (NASDAQ:TELA) Reports Mixed Q3 2025 Results, Misses Revenue Estimates ↗
TELA Bio reports Q3 2025 results with 9% revenue growth to $20.7M, missing estimates. The company improved its net loss and secured new financing for future expansion. 
Via Chartmill
News headline image
TELA Bio Announces Pricing of $13.0 Million Underwritten Registered Direct Offering of Common Stock and Pre-Funded Warrants
From TELA Bio, Inc.
Via GlobeNewswire
News headline image
TELA Bio Reports Third Quarter 2025 Financial Results and Refinancing and Upsizing of Credit Facility
From TELA Bio, Inc.
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.